AVIR - Company ID 0001593899
Atea Pharmaceuticals, Inc. trades as AVIR. This page tracks Atea Pharmaceuticals, Inc. through 301 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade (amended) | 4/A | 2026-05-21 |
| Insider trade | 4 | 2026-05-20 |
| Quarterly report | 10-Q | 2026-05-12 |
| Major company event | 8-K | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-06 |
| Proxy materials | DEFA14A | 2026-04-27 |
| Proxy statement | DEF 14A | 2026-04-27 |
| SCHEDULE 13G/A | - | 2026-03-26 |
The largest companies sharing Atea Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Atea Pharmaceuticals, Inc. reported a net loss of $158.00M.